Cargando…

Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma

BACKGROUND: Pulmonary neuroendocrine neoplasms can be divided into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell (lung) carcinoma. According to the World Health Organization, these four neoplasms have different characteristics and morphological traits, mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Wang, Weiya, Hu, Qianrong, Liang, Zuoyu, Zhou, Ping, Tang, Yuan, Jiang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951721/
https://www.ncbi.nlm.nih.gov/pubmed/35331190
http://dx.doi.org/10.1186/s12885-022-09391-w
_version_ 1784675455896387584
author Zhang, Ying
Wang, Weiya
Hu, Qianrong
Liang, Zuoyu
Zhou, Ping
Tang, Yuan
Jiang, Lili
author_facet Zhang, Ying
Wang, Weiya
Hu, Qianrong
Liang, Zuoyu
Zhou, Ping
Tang, Yuan
Jiang, Lili
author_sort Zhang, Ying
collection PubMed
description BACKGROUND: Pulmonary neuroendocrine neoplasms can be divided into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell (lung) carcinoma. According to the World Health Organization, these four neoplasms have different characteristics and morphological traits, mitotic counts, and necrotic status. Importantly, “a grey-zone” neoplasm with an atypical carcinoid-like morphology, where the mitotic rate exceeds the criterion of 10 mitoses per 2 mm(2), have still not been well classified. In clinical practice, the most controversial area is the limit of 11 mitoses to distinguish between atypical carcinoids and large cell neuroendocrine carcinomas. METHODS: Basic and clinical information was obtained from patient medical records. A series of grey-zone patients (n = 8) were selected for exploring their clinicopathological features. In addition, patients with atypical carcinoids (n = 9) and classical large cell neuroendocrine carcinomas (n = 14) were also included to compare their similarity to these neoplasms with respect to tumour morphology and immunohistochemical staining. RESULTS: We found that these grey-zone tumour sizes varied and affected mainly middle-aged and older men who smoked. Furthermore, similar gene mutations were found in the grey-zone neoplasms and large cell neuroendocrine carcinomas, for the mutated genes of these two are mainly involved in PI3K-Akt signal pathways and Pathways in cancer, including a biallelic alteration of TP53/RB1 and KEAP1. CONCLUSIONS: Our findings indicate that neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic counts is more similar to large cell neuroendocrine carcinoma than atypical carcinoid. Furthermore, this study may help improve diagnosing these special cases in clinical practice to avoid misdiagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09391-w.
format Online
Article
Text
id pubmed-8951721
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89517212022-03-26 Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma Zhang, Ying Wang, Weiya Hu, Qianrong Liang, Zuoyu Zhou, Ping Tang, Yuan Jiang, Lili BMC Cancer Research BACKGROUND: Pulmonary neuroendocrine neoplasms can be divided into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell (lung) carcinoma. According to the World Health Organization, these four neoplasms have different characteristics and morphological traits, mitotic counts, and necrotic status. Importantly, “a grey-zone” neoplasm with an atypical carcinoid-like morphology, where the mitotic rate exceeds the criterion of 10 mitoses per 2 mm(2), have still not been well classified. In clinical practice, the most controversial area is the limit of 11 mitoses to distinguish between atypical carcinoids and large cell neuroendocrine carcinomas. METHODS: Basic and clinical information was obtained from patient medical records. A series of grey-zone patients (n = 8) were selected for exploring their clinicopathological features. In addition, patients with atypical carcinoids (n = 9) and classical large cell neuroendocrine carcinomas (n = 14) were also included to compare their similarity to these neoplasms with respect to tumour morphology and immunohistochemical staining. RESULTS: We found that these grey-zone tumour sizes varied and affected mainly middle-aged and older men who smoked. Furthermore, similar gene mutations were found in the grey-zone neoplasms and large cell neuroendocrine carcinomas, for the mutated genes of these two are mainly involved in PI3K-Akt signal pathways and Pathways in cancer, including a biallelic alteration of TP53/RB1 and KEAP1. CONCLUSIONS: Our findings indicate that neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic counts is more similar to large cell neuroendocrine carcinoma than atypical carcinoid. Furthermore, this study may help improve diagnosing these special cases in clinical practice to avoid misdiagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09391-w. BioMed Central 2022-03-24 /pmc/articles/PMC8951721/ /pubmed/35331190 http://dx.doi.org/10.1186/s12885-022-09391-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Ying
Wang, Weiya
Hu, Qianrong
Liang, Zuoyu
Zhou, Ping
Tang, Yuan
Jiang, Lili
Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
title Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
title_full Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
title_fullStr Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
title_full_unstemmed Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
title_short Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
title_sort clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951721/
https://www.ncbi.nlm.nih.gov/pubmed/35331190
http://dx.doi.org/10.1186/s12885-022-09391-w
work_keys_str_mv AT zhangying clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma
AT wangweiya clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma
AT huqianrong clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma
AT liangzuoyu clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma
AT zhouping clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma
AT tangyuan clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma
AT jianglili clinicandgeneticsimilarityassessmentsofatypicalcarcinoidneuroendocrineneoplasmwithatypicalcarcinoidmorphologyandelevatedmitoticcountandlargecellneuroendocrinecarcinoma